Back to search

Aristotle University Of Thessaloniki (AUTH)

Μελέτη της έκφρασης των ενζύμων και ομάδας γονιδίων που εμπλέκονται στο μεταβολισμό φαρμάκων και ξενοβιοτικών ουσιών σε όγκους εγκεφάλου

Abstract

dc:description

We set out to study the expression profile of various genes and their respective proteins that are related to drug metabolism in human brain tumors. Brain tumor samples were collected only from newly diagnosed patients that hadn’t undergone previous radiation or chemotherapy. Using western blotting and quantitative real time PCR the protein and mRNA expression of aldehyde oxidase-1 (AOX1), glutathione-S-transferase (GSTs) -P, -T, M and cytochrome P450 1A1 (CYP1A1) were assessed. The gene expression profile of aldehyde dehydrogenase 3A1 (ALDH3A1) and cytochrome P450 1B1 (CYP1B1) were also evaluated. A total of 77 specimens were analyzed. We determined the expression of five proteins (CYP1A1, AOX1, GSTP, GSTT, and GSTM) in 54 surgical samples. We compared for any significant difference in the mean protein expression between meningiomas and astrocytomas. On average meningiomas expressed higher AOX1, GSTP and GSTM levels than astrocytomas (AOX: p=0,03, GSTP: p=0,009 and GSTM: p<0,001) but lower CYP1A1 levels (p=0,01). Correlation between the four degrees of malignancy (WHO I-IV) and the protein expression levels was evaluated. A significant negative correlation between malignancy grade and protein levels for AOX, GSTP and GSTM (p=0,002, p=0,004 and p=0,006 respectively) was reported. We also examined for any differences among the levels of the transcript product in a total of 47 tissue specimens. There were 20 meningiomas, 15 astrocytomas and 5 metastases. mRNA levels of CYP1B1, AOX1, GSTP1 and GSTM3 were significantly affected by the underlying pathology (p<0,05). Meningiomas had consistently higher mRNA levels than astrocytomas for the four abovementioned genes (UCYP1B1=33,5, p<0,001, UAOX1=14, p<0,001, UGSTP1=34, p<0,001 and UGSTM3=76,5, p=0,013). When comparing meningiomas with the metastasis group, the two genes that demonstrated the highest mRNA levels, namely AOX1 (M=12,81) and GSTM3 (M=7,89) retained their statistical significance in the difference between the two groups (UAOX1=5, p=0,001 and UGSTM3=8, p=0,002respectively). Lastly, the comparison among astrocytomas and adenocarcinomas only revealed a significant difference for the GSTP1 gene (UGSTP1=8, p=0,007). There was a significant negative correlation between malignancy grade and mRNA levels for AOX, GSTP1, GSTM3 and also for CYP1B1 (p=0,002, p=0,001, p=0,006 and p<0,001 respectively). For 32 samples, we were able to run both western and RT-PCR analysis. There is absolutely no correlation for any of the studied genes for the meningiomas group while there is one for AOX1 (p=0,011), GSTP1 (p=0,03), GSTM3 (p=0,02) in the astrocytomas group. We showed that the various CNS tumors show different patterns of drug metabolizing enzyme (DME) expression. Meningiomas exhibited significantly higher expression levels for the DMEs studied. For AOX1, GSTP and GSTM, this was shown on both a transcriptional and a translational level. For astrocytomas, we observed a correlation between mRNA levels and the translational product.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Stavrinou, Pantelis
  • Σταυρινού, Παντελής

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/33159

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Stavrinou, Pantelis; Σταυρινού, Παντελής. Μελέτη της έκφρασης των ενζύμων και ομάδας γονιδίων που εμπλέκονται στο μεταβολισμό φαρμάκων και ξενοβιοτικών ουσιών σε όγκους εγκεφάλου. Aristotle University Of Thessaloniki (AUTH), 2011. http://hdl.handle.net/10442/hedi/33159